Gyre Therapeutics Inc (STU:L9S)
€ 13.6 -0.1 (-0.73%) Market Cap: 1.33 Bil Enterprise Value: 1.30 Bil PE Ratio: 0 PB Ratio: 21.33 GF Score: 30/100

Catalyst Biosciences, Inc. - Special Call Transcript

Jul 08, 2019 / 12:00PM GMT
Operator

Greetings, and welcome to the Catalyst Biosciences ISTH Data Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to Catalyst Biosciences. Thank you. You may begin.

Unidentified Participant

Thank you, and welcome to the investor update call following the data presentations at the ISTH meeting. Joining me are Dr. Nassim Usman, President and Chief Executive Officer; Dr. Howard Levy, Chief Medical Officer; Fletcher Payne, Chief Financial Officer; and Dr. Grant Blouse, Vice President Translational Research.

Before we begin, I would like to remind you that various remarks that we make on this call contain forward-looking statements, including statements regarding expected regulatory and clinical actions and developments and projected operating expenses. These statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied in the statements themselves.

All forward-looking statements made on this call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot